Exdensur (depemokimab) approved by US FDA for the treatment of …
2 days ago · Exdensur is the first and only ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype Approval based on SWIFT trials …
Current state of biologics in treating eosinophilic esophagitis
Jan 1, 2023 · Eosinophilic esophagitis (EoE) is a chronic, allergen-mediated, eosinophil-predominant, type 2 inflammatory disease that progresses to fibrostenosis of the esophagus if left untreated. This …
Management of Eosinophilic Esophagitis - aap.org
Dupilumab, a monoclonal antibody to IL-4 receptor alpha, is the first biologic treatment for EoE approved by the Food and Drug Administration. It is approved for EoE in children 12 years and older who …
Is Dupixent Fda Approved For Eosinophilic Esophagitis
Oct 9, 2025 · Does Dupixent Treat Eosinophilic Dermatitis (EOE)? Dupixent (dupilumab) is the first and only FDA-approved biologic treatment for eosinophilic esophagitis (EoE). It is indicated for adult and …
DUPIXENT® (dupilumab) For Eosinophilic Esophagitis
Learn more about DUPIXENT® (dupilumab), the first FDA-approved biologic to treat eosinophilic esophagitis (EoE) in adult and pediatric patients aged 1 year and older who weigh at least 33lb …
The role of dupilumab in the treatment of eosinophilic esophagitis
Jul 29, 2024 · Dupilumab has been approved to treat a variety of atopic disorders and was the first US FDA-approved medication for the treatment of eosinophilic esophagitis (EoE), initially approved in …
Evolution of EoE Pharmacologic Therapies – May 2025
Explore the evolution of pharmacologic treatments for eosinophilic esophagitis (EoE), including proton pump inhibitors, topical corticosteroids, and biologic agents, highlighting advancements and future …
Eosinophilic Esophagitis Treatment With Dupixent - WebMD
Jun 12, 2024 · Dupixent is an injectable biologic medicine. Here’s how it helps with eosinophilic esophagitis.
New drug approvals are reshaping the landscape of Eosinophilic ...
Feb 16, 2024 · The FDA has granted approval for two medications in the treatment of Eosinophilic Esophagitis (EoE)—the first oral medication tailored for adults and the exclusive therapeutic option …
FDA Approves GSK's Exdensur as Twice-Yearly Add-On Therapy for …
19 hours ago · Key Takeaways Exdensur is approved for severe asthma with an eosinophilic phenotype, reducing exacerbations with twice-yearly dosing. Phase III trials showed Exdensur significantly …